Hiroshima, Japan

Takeshi Kawamoto



Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Yamaguchi, JP (2002)
  • Hiroshima, JP (2016)

Company Filing History:


Years Active: 2002-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Takeshi Kawamoto

Introduction

Takeshi Kawamoto is a notable inventor based in Hiroshima, Japan. He has made significant contributions to the field of regenerative medicine, particularly through his innovative methods for distinguishing mesenchymal stem cells. With a total of 2 patents, his work has the potential to impact therapeutic applications in this vital area of research.

Latest Patents

Kawamoto's latest patents include a method for distinguishing mesenchymal stem cells using molecular markers. This method involves detecting differences in gene expression between mesenchymal stem cells and connective tissue cells, allowing for accurate identification of undifferentiated mesenchymal stem cells. His second patent focuses on a gene specifically expressed in differentiated human chondrocytes, which can be obtained by culturing chondrocytes in the presence of dibutyryl cAMP. This research is crucial for advancing regenerative medicine.

Career Highlights

Throughout his career, Takeshi Kawamoto has worked with prominent companies such as Chugai Seiyaku Kabushiki Kaisha and Two Cells Co., Ltd. His experience in these organizations has contributed to his expertise in the field of stem cell research and regenerative medicine.

Collaborations

Kawamoto has collaborated with notable coworkers, including Yukio Kato and Koichiro Tsuji. Their combined efforts have furthered the understanding and application of stem cell technologies.

Conclusion

Takeshi Kawamoto's innovative work in distinguishing mesenchymal stem cells and his contributions to regenerative medicine highlight his importance as an inventor. His patents and collaborations reflect a commitment to advancing medical science and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…